Extra-renal 1α-Hydroxylase Activity and Human Disease

Vitamin D

Volumn 2, Issue , 2005, Pages 1379-1400

  Hewison, Martin ^a   Adams, John S ^b,c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884844755     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012252687-9/50082-6     Document Type: Chapter

References (240)

1. Harrell GT, Fisher S Blood chemical changes in Boeck's sarcoid. J Clin Invest 1939, 18:687-693.
2. Henneman PH, Dempsey EF, Carrol EJ, Albright F The causes of hypercalcemia in sarcoid and its treatment with cortisone. J Clin Invest 1956, 35:1229-1242.
3. Taylor RL, Lynch HJ, Wysor WG Seasonal influence of sunlight on the hypercalcemia of sarcoidosis. Am J Med 1963, 35:67-89.
4. Dent CE, Flynn FV, Nabarro JDN Hypercalcemia and impairment of renal function in generalized sarcoidosis. Br Med J 1953, 2:808-810.
5. Hendrix JZ The remission of hypercalcemia and hypercalciuria in systemic sarcoidosis by vitamin D depletion. Clin Res 1963, 11:220-225.
6. Bell NH, Gill JR, Barter FC Abnormal calcium absorption, in sarcoidosis: evidence for increased sensitivity to vitamin D. Am J Med 1964, 36:500-513.
7. Holick MF, Schnoes THK, DeLuca HF, Suda T, Cousins RJ Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. J NIH Res 1992, 4:88-96.
8. Bell NH Vitamin D endocrine system. J Clin Invest 1985, 76:1-6.
9. 3. J Clin Invest 1976, 58:61-70.
10. Clemens TL, Hendy GN, Graham RF A radioimmunoassay for 1,25-dihydroxycholecalciferol. Clin Sci Mol Med 1978, 54:329-332.
11. 3. Vitamin D Basic Research and Its Clinical Application 1979, 763-767. de Gruyter, Berlin. A.W. Norman, K. Schaefer, D. von-Herrath (Eds.).
12. Bouillon R, DeMoor P, Baggiolini EG, Uskokovic MR A radioimmunoassay for 1,25-dihydroxycholecalciferol. Clin Chem 1980, 26:562-567.
13. Holick MF The use and interpretation of assays for vitamin D and its metabolites. J Nutr 1990, 120:1464-1469.
14. Bell NH, Stern PH, Pantzer E, Sinha TK, DeLuca Evidence that increased circulating 1,25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest 1999, 64:218-225.
15. Papapoulos SE, Clemens TL, Fraher LJ, Lewin IG, Sandler LM, O'Riordan JL 1,25-Dihydroxycholecalciferol in the pathogenesis of the hypercalcemia of sarcoid. Lancet 1979, 1:627-630.
16. Stern PH, Olazabal J, Bell NH Evidence for abnormal regulation of circulating 1,25-dihydroxyvitamin D in patients with sarcoidosis. J Clin Invest 1980, 66:852-855.
17. Barbour GL, Coburn JW, Slatopolsky E, Norman AW, Horst RL Hypercalcemia in an anephric patient with sarcoidosis. N Engl J Med 1981, 305:440-443.
18. 3 by cultured alveolar macrophages in sarcoidosis. J Clin Invest 1983, 72:1856-1860.
19. 3 produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab 1985, 60:960-966.
20. 3 1α-hydroxylase and vitamin D synthesis. Science 1997, 277:1827-1830.
21. Fu GK, Lin D, Zhang MY, Bikle DD, Shackleton CH, Miller WL, Portale AA Cloning of human 25-hydroxyvitamin D-1α-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol 1997, 11:1961-1970.
22. Smith SJ, Rucka AK, Berry JL, Davies M, Mylchreest S, Paterson CR, Heath DA, Tassabehji M, Read AP, Mee AP, Mawer EB Novel mutations in the 1α-hydroxylase (P450c1) gene in three families with pseudovitamin D-deficiency rickets resulting in loss of functional enzyme activity in blood-derived macrophages. J Bone Miner Res 1999, 14:730-739.
23. Zehnder D, Bland R, Walker EA, Bradwell AR, Howie AJ, Hewison M, Stewart PM Expression of 25-hydroxyvitamin D 3-1α-hydroxylase in the human kidney. J Am Soc Nephrol 10:2465-2473.
24. 3-1α-hydroxylase. J Clin Endo Metab 2001, 86:888-894.
25. Bell NH Endocrine complications of sarcoidosis. Endo Metab Clin North Am 1991, 20:645-654.
26. Basile JN, Leil Y, Shary J, Bell NH Increased calcium intake does not suppress circulating 1,25-dihydroxyvitamin D in normocalcemic patients with sarcoidosis. J Clin Invest 1993, 91:1396-1398.
27. Sandler LM, Winearls CG, Fraher LJ, Clemens TL, Smith R, O'Riordan JLH Studies of the hypercalcemia of sarcoidosis. Quart J Med 1984, 53:165-180.
28. Papapoulos SE, Clemens TL, Fraher LJ Dihydroxycholecalciferol in the pathogenesis of the hypercalcemia of sarcoid. Lancet 1979, 1:627-630.
29. Cronin CC, Dinneen SF, O'Mahony MS, Bredin CP, O'Sullivan DJ Precipitation of hypercalcemia in sarcoidosis by foreign sun holidays: report of four cases. Postgrad Med J 1990, 66:307-309.
30. Insogna KL, Dreyer BE, Mitnich M, Ellison AF, Broadus A Enhanced production of 1,25-dihydroxyvitamin D in sarcoidosis. J Clin Endocrinol Metab 1988, 66:72-75.
31. Stern PH, De Olazabal J, Bell NH Evidence for abnormal regulation of circulating 1α,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism. J Clin Invest 1980, 66:852-855.
32. Shulman LE, Schoenrich E, Harvey A The effects of adrenocorticotropic hormone (ACTH) and cortisone on sarcoidosis. Bull John Hopkins Hosp 1952, 91:371-415.
33. Anderson J, Dent CE, Harper C, Philpot GR Effect of cortisone on calcium metabolism in sarcoidosis with hypercalcemia. Lancet 1954, 2:720-724.
34. O'Leary TJ, Jones G, Yip A, Lohnes D, Cohanim M, Yendt ER The effects of chloroquine on serum 1,25-dihydroxyvitamin D and calcium metabolism in sarcoidosis. N Engl J Med 1986, 315:727-730.
35. Barre PE, Gascon-Barre M, Meakins JL, Goltzman D Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis. Am J Med 1987, 82:1259-1262.
36. Adams JS, Diz MM, Sharma OP Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann Int Med 1989, 111:437-438.
37. Singer FR, Adams JS Abnormal calcium homeostasis in sarcoidosis. N Engl J Med 1986, 315:755-756.
38. Meyrier A, Valeyre D, Bouillon R, Paillard F, Battesti JP, Georges R Resorptive versus absorptive hypercalciuria in sarcoidosis. Quart J Med 1985, 54:269-281.
39. Adams JS, Gacad MA, Anders A, Endres DB, Sharma DP Biochemical indicators of disordered vitamin D and calcium homeostasis in sarcoidosis. Sarcoidosis 1986, 3:1-6.
40. 3 sterols by cultured macrophages from patients with sarcoidosis. J Exp Med 1985, 161:755-765.
41. 3-1-hydroxylase and partial purification from the chick myelomonocytic cell line HD-11. J Bone Min Res 1993, 8:269-276.
42. 3 in chick myelomonocytic cell line HD-11. Endocrinology 1994, 134:2567-2573.
43. 3 by interferon-gamma-stimulated normal human bone marrow and alveolar macrophages. J Biol Chem 1987, 262:10931-10937.
44. Fraser DR Regulation of the metabolism of vitamin D. Physiol Rev 1980, 60:551-613.
45. 3 1α-hydroxylase from rat kidney mitochondria. FEBS Lett 1997, 419:45-48.
46. 3 to calcitroic acid. Eur J Biochem 1999, 262:43-48.
47. Reichel H, Koeffler HP, Norman AW The role of the vitamin D endocrine system in health and disease. N Engl J Med 1989, 320:980-991.
48. Taylor R A new receptor for calcium ions. J NIH Res 1994, 6:25-27.
49. Garabedian M, Holick MF, DeLuca HF, Boyle IT Control of 25-hydroxy-cholecalciferol metabolism by parathyroid glands. Proc Natl Acad Sci 1972, 69:1973-1976.
50. 3. Biochem Biophys Res Commun 1998, 249:11-16.
51. 3-1α-hydroxylase gene. Proc Natl Acad Sci USA 1999, 96:6988-6993.
52. Henry HL Vitamin D hydroxylases. J Cell Biochem 1992, 49:4-9.
53. Portale AA, Halloran BP, Murphy MM, Morris RC Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans. J Clin Invest 1986, 77:7-12.
54. Tenenhouse HS, Martel J, Gauthier C, Zhang MY, Portale AA Renal expression of the sodium/phosphate cotransporter gene, Npt2, is not required for regulation of renal 1 alpha-hydroxylase by phosphate. Endocrinology 2001, 142:1124-1129.
55. 3 production by cultured alveolar macrophages from normal human donors and patients with pulmonary sarcoidosis. J Clin Endocrinol Metab 1987, 65:1201-1209.
56. Hakeda Y, Hiura K, Sato T, Okazaki R, Matsumoto T, Ogata E, Ishitani R, Kumegawa M Existence of parathyroid hormone-binding sites on murine hemopoietic blast cells. Biochem Biophys Res Commun 1989, 163:1481-1486.
57. 3 synthesis in macrophages from arthritic joints by phorbol ester, dibutyryl-cAMP and calcium ionophore (A23187). FEBS Lett 1992, 311:71-74.
58. 3-1α-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium. Endocrinology 1999, 140:2027-2034.
59. Nesbitt T, Drezner MK Insulin-like growth factor-1 regulation of renal 25-hydroxyvitamin D-1α-hydroxylase activity. Endocrinology 1993, 132:133-138.
60. 3 metabolism in kidney cell cultures: lack of a direct effect of estradiol. Am J Physiol 1981, 240:E119-E124.
61. Adams ND, Garthwaite TL, Gray RW The interrelationship among prolactin, 1,25-dihydroxyvitamin D, and parathyroid hormone in humans. J Clin Endocrinol Metab 1979, 49:628-630.
62. Kumar R, Merimee TJ, Silva P, Epstein FH The effect of chronic excess or deficiency of growth hormone on plasma 1,25-dihydroxyvitamin D levels in man. Vitamin D, Basic Research and Its Clinical Application 1979, 1005-1009. de Gruyter, Berlin. A.W. Norman, K. Schaefer, D. von Herrath (Eds.).
63. Brixen K, Nielsen HK, Bouillon R, Flyvbjerg A, Mosekilde L Effects of short-term growth hormone treatment on PTH, calcitriol, thyroid hormones, insulin, and glucagon. Acta Endocrinol 1992, 127:331-336.
64. Omdahl JL, Bobrovnikova EA, Choe S, Dwivedi PP, May BK Overview of regulatory cytochrome P450 enzymes of the vitamin D pathway. Steroids 2001, 66:381-389.
65. 3 24-hydroxylase. FEBS Letter 1991, 278:195-198.
66. 3 24-hydroxylase cDNA. J Bone Mineral Res 1992, 7:S148.
67. 3-24-hydroxylase. Proc Natl Acad Sci 1993, 90:4543-4547.
68. 3 and parathyroid hormone. J Bone Min Res 1993, 8:S208-S212.
69. 3 induced expression of the 24-hydroxylase gene. J Bone Min Res 1993, 8:S171.
70. 3-24-hydroxylase cytochrome P-450 messenger ribonucleic acid levels in primary cultures of rat renal cells. Endocrinology 1993, 132:1782-1788.
71. 3 and parathyroid hormone. J Cell Biochem 2003, 88:234-237.
72. 3 in vivo and in primary cultures of chick kidney cells. J Biol Chem 1979, 254:2722-2729.
73. Inouye K, Sakaki T Enzymatic studies on the key enzymes of vitamin D metabolism; 1α-hydroxylase (CYP27B1) and 24-hydroxylase (CYP24). Biotechnol Annu Rev 2001, 7:179-194.
74. 3 autoregulation in keratinocytes. J Biol Chem 2002, 277:36987-36990.
75. 3 by pulmonary alveolar macrophages from patients with sarcoidosis. NY Acad Sci 1986, 465:587-594.
76. Adams JS Hypercalcemia and hypercalciuria. Sem Resp Med 1992, 13:402-410.
77. Adams JS, Modlin RL, Diz MM, Barnes PF Potentiation of the macrophage 25-hydroxyvitamin D-1α-hydroxylation reaction by human tuberculous pleural effusion fluid. J Clin Endocrinol Metab 1989, 69:457-460.
78. Hunninghake GW Role of alveolar macrophage and lung T-cell derived mediators in pulmonary sarcoidosis. Ann NY Acad Sci 1986, 465:82-90.
79. Pryke AM, Duggan C, White CP, Posen S, Mason RS Tumor necrosis factor-alpha induces vitamin D-1-hydroxylase activity in normal human alveolar macrophages. J Cell Physiol 1990, 142:652-656.
80. Platanias LC, Fish EN Signaling pathways activated by interferons. Exp Hematol 1999, 27:1583-1592.
81. Imada K, Leonard WJ The Jak-STAT pathway. Mol Immunol 2000, 37:1-11.
82. Ishihara K, Hirano T Molecular basis of the cell specificity of cytokine action. Biochim Biophys Acta 2002, 1592:281-296.
83. Xaus J, Comalada M, Valledor AF, Cardo M, Herrero C, Soler C, Lloberas J, Celada A Molecular mechanisms involved in macrophage survival, proliferation, activation, or apoptosis. Immunobiology 2001, 204:543-550.
84. Celada A, Schreiber RD Role of protein kinase C and intracellular calcium mobilization in the induction of macrophage tumoricidal activity by interferon-gamma. J Immunol 1996, 137:2373.
85. Wightman PD, Humes JL, Davies P, Bonney RJ Identification of two phospholipase A2 activities in resident mouse peritoneal macrophages. Biochem J 1981, 195:427.
86. Wightman PD, Dahlgren M, Bonney RS Protein kinase activation of phospholipase A2 in sonicates of mouse peritoneal macrophages. J Biol Chem 1982, 257:6650.
87. Adams JS, Gacad MA, Diz MM, Nadler JL A role for endogenous arachidonate metabolites in the regulated expression of the 25-hydroxyvitamin D-1-hydroxylation reaction in cultured alveolar macrophages from patients with sarcoidosis. J Clin Endocrinol Metab 1990, 70:595-600.
88. Sabroe I, Jones EC, Usher LR, Whyte MK, Dower SK Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J Immunol 2002, 168:4701-4710.
89. Barton GM, Medzhitov R Toll-like receptors and their ligands. Curr Top Microbiol Immunol 2002, 270:81-92.
90. Bland R, Zehnder D, Hughes SV, Ronco PM, Stewart PM, Hewison M Regulation of vitamin D-1α-hydroxylase in a human cortical collecting duct cell line. Kidney International 2001, 60:1277-1286.
91. Adams JS, Ren SY, Arbelle JE, Clemens TL, Shany S A role for nitric oxide in the regulated expression of the 25-hydroxyvitamin D-1-hydroxylation reaction in the chick myelomonocytic cell line HD-11. Endocrinology 1994, 134:499-502.
92. Adams JS, Ren S-Y, Arbelle J, Shany S, Gacad MA Coordinate regulation of nitric oxide and 1,25-dihydroxyvitamin D production in the avian myelomonocytic cell line HD-11. Endocrinology 1995, 136:2262-2269.
93. Adams JS, Ren S-Y Autoregulation of 1,25-dihydroxyvitamin D synthesis in macrophage mitochondria by nitric oxide. Endocrinology 1996, 137:4514-4517.
94. Marletta MA Nitric oxide synthase: aspects concerning structure and catalysis. Cell 1994, 78:927-930.
95. Nathan C, Xie Q-W Nitric oxide synthases: Roles, tolls, and controls. Cell 1994, 78:915-918.
96. Salkowski CA, Detore G, McNally R, van Rooijen N, Vogel SN Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling. J Immunol 1997, 158:905-912.
97. Alley EW, Murphy WJ, Russell SW A classical enhancer element responsive to both lipopolysaccharide and interferon-gamma augments induction of the iNOS gene in mouse macrophages. Gene 1995, 158:247-251.
98. White KA, Marletta MA Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry 1992, 31:6627-6631.
99. Khatsenko OG, Gross SS, Rifkind AB, Vane JR Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc Natl Acad Sci 1993, 90:11147-11151.
100. Stadler J, Trockfeld J, Schmalix WA, Brill T, Siewert JR, Greim H, Doehmer J Inhibition of cytochromes P450-1A by nitric oxide. Proc Natl Acad Sci 1994, 91:3559-3563.
101. Van Voorhis BJ, Dunn MS, Snyder GD, Weiner CP Nitric oxide: An autocine regulator of human granulosaluteal cell steroidogenesis. Endocrinology 1994, 135:1799-1806.
102. Hartl FU Molecular chaperones in cellular protein folding. Nature 1996, 381:571-580.
103. Rutherford SL, Zucker CS Protein folding and the regulation of signaling pathways. Cell 1994, 79:1129-1132.
104. Minowada G, Weich WJ Clinical implications of the stress response. J Clin Invest 1995, 95:3-12.
105. Moseley P Stress proteins and the immune response. Immunopharmacol 2000, 48:299-302.
106. More S, Breloer M, Fleischer B, von Bonin A Activation of cytotoxic T-cells in vitro by recombinant gp96 fusion proteins irrespective of the "fused" antigenic peptide sequence. Immunol Lett 1999, 69:275-282.
107. Wallin RP, Lundqvist A, More SH, von Bonin A, Kiessling R, Ljunggren HG Heat-shock proteins as activators of the innate immune system. Trends Immunol 2002, 23:130-135.
108. Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels RD, Wagner H HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem 2002, 277:15107-15112.
109. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, Stevenson MA, Calderwood SK Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 2002, 277:15028-15034.
110. Berthold J, Bauer MF, Schneider H-C, Klaus C, Dietmeier K, Neupert W, Brunner M The MIM complex mediates preprotein translocation across the mitochondrial inner membrane and couples it to the mt-Hsp70/ATP driving system. Cell 1995, 81:1085-1093.
111. Brodsky JL Post-translational protein translocation; not all hsc70s are created equal. Trends Biochem Sci 1996, 21:122-126.
112. Voos W, Martin H, Krimmer T, Pfanner N Mechanisms of protein translocation into mitochondria. Biochim Biophys Acta 1999, 1422:235-254.
113. 3 modulates heat shock response in monocytes. Am J Physiol 1987, 252:C640-C649.
114. 3 and 17-beta-estradiol. J Clin Endocrinol Metab 1998, 83:1264-1267.
115. Gacad MA, Chen H, Arbelle JE, LeBon T, Adams JS Functional characterization and purification of an intracellular vitamin D-binding protein in vitamin D-resistant new world primate cells. Amino acid sequence homology with proteins in the hsp-70 family. J Biol Chem 1997, 272:8433-8440.
116. Wu S, Ren S, Chen H, Chun RF, Gacad MA, Adams JS Intracellular vitamin D-binding proteins: novel facilitators of vitamin D-directed transactivation. Mol Endocrinol 2000, 14:1387-1397.
117. Adams JS, Chen H, Chun RF, Nguyen L, Wu S, Ren SY, Barsony J, Gacad MA Novel regulators of vitamin D action and metabolism: Lessons learned at the Los Angeles zoo. J Cell Biochem 2003, 88:308-314.
118. 3. Cell 1999, 96:507-515.
119. 3. Curr Opin Lipidol 2002, 13:255-260.
120. 3 receptors in human leukocytes. Science 1983, 221:1181-1182.
121. 3 in human peripheral blood mononuclear cells. J Clin Endocrinol Metab 1983, 57:1308-1310.
122. Rigby W The immunobiology of vitamin D. Immunol Today 1988, 9:54-58.
123. Hewison M Vitamin D and the immune system. J Endocrinology 1992, 132:173-175.
124. Fagan DL, Prehn JL, Jordan SC, Adams JS The human myelomonocytic cell line U937 as a model for studying alterations in monokine gene expression by 1,25-dihydroxyvitamin D. Mol Endocrinol 1991, 5:179-186.
125. 3. Blood 1992, 80:2811-2816.
126. 3. Proc Natl Acad Sci USA 1983, 80:5907-5910.
127. 3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol 1986, 98:311-322.
128. Ucla C, Roux-Lombard P, Dayer J-M, Mach B IFNγ drastically modifies the regulation of IL-1 genes by endotoxin in U937 cells. J Clin Invest 1990, 85:185-191.
129. 3. J Immunol 1986, 136:2181-2186.
130. 3, gamma-interferon, and control of proliferation of mycobacterium tuberculosis by human monocytes. Immunology 1986, 57:159-163.
131. 3 activates secretion of hydrogen peroxide by human monocytes. J Immunol 1986, 136:1049-1053.
132. 3. Blood 1990, 76:189-197.
133. 3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T-cell activation. J Immunol 2000, 164:2405-2411.
134. 3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 2001, 98:6800-6805.
135. 3 affects differentiation, maturation, and function of human monocytederived dendritic cells. J Immunol 2000, 164:4443-4451.
136. 3 inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 2000, 28:575-583.
137. Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG, Kilby MD, Moss PA, Chakraverty R Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 2003, 170:5382-5890.
138. 3 by human dendritic cells. Blood 2003.
139. Deluca HF, Cantorna MT Vitamin D: its role and uses in immunology. FASEB J 2001, 15:2579-2585.
140. 3. J Cell Biochem 1992, 49:26-31.
141. Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC 1,25-dihydroxyvitamin D suppresses human T helper-inducer lymphocyte activity in vitro. J Immunol 1985, 134:219-224.
142. 3, a novel immunoregulatory hormone. Science 1984, 224:1438-1440.
143. 3. Immunol 1986, 59:479-484.
144. 3 on human T lymphocyte activation and proliferation. J Immunol 1985, 135:2279-2286.
145. 3. J Clin Invest 1987, 79:1659-1664.
146. Lemire JM, Adams JS, Sakai R, Jordan SC 1,25-dihydroxyvitamin D suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 1984, 74:857-861.
147. Lemire JM, Adams JS 1,25-dihydroxyvitamin D inhibits delayed-type hypersensitivity mediated by T-cell clones inducing experimental auto-immune encephalomyelitis. J Bone Min Res 1992, 7:171-178.
148. 3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001, 167:4974-4980.
149. 3: preferential inhibition of Th1 functions. J Nutr 1995, 125(6):1704S-1708S. Suppl.
150. Rook GA, Hernandez-Pando R, Lightman SL Hormones, peripherally activated prohormones, and regulation of the Th1/Th2 balance. Immunol Today 1994, 15:301-303.
151. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL, Hawrylowicz CM, O'Garra A In vitro generation of interleukin 10-producing regulatory CD4(+) T-cells is induced by immuno-suppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002, 195:603-616.
152. 3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001, 167:1945-1953.
153. Adorini L Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T-cells inhibiting autoimmune diabetes. Ann NY Acad Sci 2003, 987:258.
154. Aslam SM, Garlich JD, Qureshi MA Vitamin D deficiency alters the immune responses of broiler chicks. Poult Sci 1998, 77:842-849.
155. Yang S, Smith C, Prahl JM, Luo X, DeLuca HF Vitamin D deficiency suppresses cell-mediated immunity in vivo. Arch Biochem Biophys 1993, 303:98-106.
156. McMurray DN, Bartow RA, Mintzer CL, Hernandez-Frontera E Micronutrient status and immune function in tuberculosis. Ann NY Acad Sci 1990, 587:59-69.
157. Wientroub S, Winter CC, Wahl SM, Wahl LM Effect of vitamin D deficiency on macrophage and lymphocyte function in the rat. Calcif Tissue Int 1989, 44:125-130.
158. Mariani E, Ravaglia G, Forti P, Meneghetti A, Tarozzi A, Maioli F, Boschi F, Pratelli L, Pizzoferrato A, Piras F, Facchini A Vitamin D, thyroid hormones, and muscle mass influence natural killer (NK) innate immunity in healthy nonagenarians and centenarians. Clin Exp Immunol 1999, 116:19-27.
159. Yener E, Coker C, Cura A, Keskinoglu A, Mir S Lymphocyte subpopulations in children with vitamin D-deficient rickets. Acta Paediatr Jpn 1995, 37:500-502.
160. Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. Diabetologia 1999, 42:51-54. The EURODIAB Substudy 2 Study Group.
161. Jeevan A, Kripke ML Effect of a single exposure to ultraviolet radiation on Mycobacterium bovis bacillus Calmette-Guerin infection in mice. J Immunol 1989, 143:2837-2843.
162. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Arioka K, Sato H, Uchiyama Y, Masushige S, Fukamizu A, Matsumoto T, Kato S Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia, and growth retardation after weaning. Nat Genet 1997, 16:391-396.
163. Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, Hendy GN, Goltzman D Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci U S A 2001, 98:7498-7503.
164. Mathieu C, Van Etten E, Gysemans C, Decallonne B, Kato S, Laureys J, Depovere J, Valckx D, Verstuyf A, Bouillon R In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice. J Bone Miner Res 2001, 16:2057-2065.
165. O'Kelly J, Hisatake J, Hisatake Y, Bishop J, Norman A, Koeffler HP Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. J Clin Invest 2002, 109:1091-1099.
166. Barnes PF, Modlin RL, Bikle DD, Adams JS Transpleural gradient of 1,25-dihydroxyvitamin D in tuberculous pleuritis. J Clin Invest 1989, 83:1527-1532.
167. Adams JS, Modlin RL, Diz MM, Barnes PF Potentiation of the macrophage 25-hydroxyvitamin D-1-hydroxylation reaction by human tuberculous pleural effusion fluid. J Clin Endocrinol Metab 1989, 69:457-460.
168. 3 metabolites, and tumor necrosis factor in the pathogenesis of tuberculosis. Immunology 1987, 62:229-234.
169. Rook GAW The role of vitamin D in tuberculosis. Am Rev Respir Dis 1988, 138:768-770.
170. Mawer EB, Hayes ME, Still PE, Davies M, Lumb GA, Palit J, Holt PJL Evidence for nonrenal synthesis of 1,25-dihydroxyvitamin D in patients with inflammatory arthritis. J Bone Min Res 1991, 6:733-739.
171. 3 by cultured synovial fluid macrophages and fibroblast-like cells from patients with arthritis. Ann Rheum Dis 1992, 51:220-226.
172. 3 in macrophages from CAPD patients. FEBS 1987, 220:307-310.
173. 3 by peritoneal macrophages from CAPD patients. Kid Int 1991, 39:1005-1011.
174. Barnard J, Newman LS Sarcoidosis: immunology, rheumatic involvement, and therapeutics. Curr Opin Rheumatol 2001, 13:84-91.
175. Sharma OP Vitamin D, calcium, and sarcoidosis. Chest 1996, 109:535-539.
176. Studdy PR, Bird R, Neville E, James DG Biochemical findings in sarcoidosis. J Clin Pathol 1980, 33:528-533.
177. James DG, Neville E, Siltzbach LE, et al. A worldwide review of sarcoidosis. Ann NY Acad Sci 1976, 278:321-334.
178. James DG, Siltzbach LE, Sharma OP, Carstairs LS A tale of two cities: a comparison of sarcoidosis in London and New York. Arch Intern Med 1969, 123:187-191.
179. Rizzato G, Montemurro L, Fraioli P Bone mineral content in sarcoidosis. Semin Resp Med 1992, 13:411-423.
180. Vergnon GM, Chappard D, Mounier D, et al. Phosphocalcic metabolism, bone quantitative histomorphometry, and clinical activity in 10 cases of
181. Fallon MD, Perry HM, Teitelbaum SL Skeletal sarcoidosis with osteopenia. Metab Bone Dis Res 1981, 3:171-174.
182. Need AG, Phillips PJ Hypercalcemia associated with tuberculosis. Br Med J 1980, 280:831.
183. Felsenfeld AJ, Drezner MK, Llach F Hypercalcemia and elevated calcitriol in a maintenance dialysis patient with tuberculosis. Arch Intern Med 1945, 146:1941-1945.
184. Gkonos PJ, London R, Hendler ED Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis. N Engl J Med 1984, 311:1683-1685.
185. Epstein S, Stern PH, Bell NH, Dowdeswell I, Turner RT Evidence for abnormal regulation of circulating 1α,25-dihydroxyvitamin D in patients with pulmonary tuberculosis and normal calcium metabolism. Calcif Tissue Int 36:541-544.
186. Bell NH, Shary J, Shaw S, Turner RT Hypercalcemia associated with increased circulating 1,25-dihydroxyvitamin D in a patient with pulmonary tuberculosis. Calcif Tissue Int 1985, 37:588-591.
187. 3 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis. J Clin Invest 1990, 85:1588-1593.
188. Cadranel JL, Garabedian M, Milleron B, Guillozzo H, Valeyre D, Paillard F, Akoun G, Hance AJ Vitamin D metabolism by alveolar immune cells in tuberculosis: correlation with calcium metabolism and clinical manifestations. Eur Res J 1994, 7:1103-1110.
189. Isaacs RD, Nicholson GI, Holdaway IM. Miliary tuberculosis with hypercalcemia and raised vitamin D concentrations. Thorax 42:555-556.
190. Shai F, Baker RK, Addrizzo JR, Wallach S Hypercalcemia in mycobacterial infection. J Clin Endocrinol Metab 1972, 34:251-256.
191. Braman SS, Goldman AL, Schwarz MI Steriod-responsive hypercalcemia in disseminated bone tuberculosis. Arch Intern Med 1973, 90:327-328.
192. Hoffman VH, Korzeniowski OM Leprosy, hypercalcemia, and elevated serum calcitriol levels. Ann Intern Med 1986, 105:890-891.
193. Ryzen E, Rea TH, Singer FR Hypercalcemia and abnormal 1,25-dihydroxyvitamin D concentrations in leprosy. Am J Med 1988, 84:325-329.
194. Kantarijian HM, Saad MF, Estey EH, Sellin RV, Samaan NA Hypercalcemia in disseminated candidiasis. Am J Med 1983, 74:721-724.
195. Walker JV, Baran D, Yakub YN, Freeman RB Histoplasmosis with hypercalcemia, renal failure, and papillary necrosis. Confusion with sarcoidosis. JAMA 1977, 237:1350-1352.
196. Parker MS, Dokoh S, Woolfenden JM, Buchsbaum HW Hypercalcemia in coccidioidomycosis. Am J Med 1984, 76:341-343.
197. Ahmed B, Jaspan JB Case report: hypercalcemia in a patient with AIDS and Pneumocystis carinii pneumonia. Am J Med Sci 1993, 306:313-316.
198. Kozeny G, Barbato A, Bansal VK, Vertuno LL, Hano JE Hypercalcemia associated with silicone-induced granulomas. N Engl J Med 1984, 311:1103-1105.
199. Jurney TH Hypercalcemia in a patient with eosinophilic granuloma. Am J Med 1984, 76:527-528.
200. Edelson GW, Talpos GB, Bone HG Hypercalcemia associated with Wegener's granulomatosis and hyperparathyroidism: etiology and management. Am J Nephrol 1993, 13:275-277.
201. Al-Ali H, Yabis AA, Issa E, Salem Z, Tawil A, Khoury N, Fuleihan Gel-H Hypercalcemia in Langerhans' cell granulomatosis with elevated 1,25 dihydroxyvitamin D (calcitriol) level. Bone 2002, 30:331-334.
202. Stoeckle JD, Hardy HL, Weber AL Chronic beryllium disease. Long-term follow-up of 60 cases and selective review of the literature. Am J Med 1969, 46:545-561.
203. Cook JS, Stone MS, Hansen JR Hypercalcemia in association with subcutaneous fat necrosis of the newborn: studies of calcium-regulating hormones. Ped 1992, 90:93-96.
204. Bosch X Hypercalcemia due to endogenous over-production of 1,25-dihydroxyvitamin D in Crohn's disease. Gastroenterol 1998, 114:1061-1065.
205. Andres PG, Friedman LS Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 1999, 28:255-281.
206. Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, Holt PR, Lipkin MS, Holick MF 25-hydroxyvitamin D-1α-hydroxylase in normal and malignant colon tissue. Lancet 2001, 357:1673-1674.
207. Bareis P, Bises G, Bischof MG, Cross HS, Peterlik M 25-hydroxy-vitamin D metabolism in human colon cancer cells during tumor progression. Biochem Biophys Res Commun 2001, 285:1012-1017.
208. Ogunkolade BW, Boucher BJ, Fairclough PD, Hitman GA, Dorudi S, Jenkins PJ, Bustin SA Expression of 25-hydroxyvitamin D-1α-hydroxylase mRNA in individuals with colorectal cancer. Lancet 2002, 359:1831-1832.
209. Zaloga GP, Eil C, Medbery CA Humoral hypercalcemia in Hodgkin's disease. Arch Intern Med 1985, 145:155-157.
210. 3 in three patients with lymphoma-associated hypercalcemia. J Clin Endocrinol Metab 1985, 60:29-33.
211. Davies M, Mawer EB, Hayes ME, Lumb GA Abnormal vitamin D metabolism in Hodgkin's lymphoma. Lancet 1985, 1:1186-1188.
212. Adams JS, Fernandez M, Endres DB, Gill PS, Rasheed S, Singer FR Hypercalcemia, hypercalciuria, and elevated serum 1,25-dihydroxyvitamin D concentrations in patients with AIDS- and non-AIDS-associated lymphoma. Blood 1979, 73:235-239.
213. Seymour JF, Gagel RF Calcitriol: The major humoral mediator of hypercalcemia in Hodgkin's lymphomas. Blood 1993, 82:1383-1394.
214. Seymour JF, Gagel RF, Hagemeister FB, Dimopoulos MA, Cabanillas F Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin's lymphoma. Ann Intern Med 1994, 121:633-640.
215. Davies M, Hayes ME, Liu Yin JA, Berry JL, Mawer EB Abnormal synthesis of 1,25-dihydroxyvitamin D in patients with malignant lymphoma. J Clin Endocrinol Metab 1994, 78:1202-1207.
216. Hewison M, Kantorovich V, Liker HR, Van Herle AJ, Cohan P, Zehnder D, Adams JS Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. J Bone Miner Res 2003, 18:579-582.
217. Grote TH, Hainsworth JD Hypercalcemia and elevated serum calcitriol in a patient with seminoma. Arch Intern Med 1987, 147:2212-2213.
218. Bikle DD, Pillai S, Gee E, Hincenbergs M Tumor necrosis factorα regulation of 1,25-dihydroxyvitamin D production by human keratinocytes. Endocrinology 1991, 129:33-38.
219. 3 by perfused pig skin. J Invest Dermatol 1994, 102:796-798.
220. 3. Cancer Epidemiol Biomarkers Prev 1998, 7:391-395.
221. 3 1α-hydroxylase expression in human placenta and decidua. Am J Pathol 2002, 161:105-114.
222. 3 1α-hydroxylase gene transcription, product, in cultures of human syncytiotrophoblast cells. J Clin Endocrinol Metab 2000, 85:2543-2549.
223. 3 in vitro synthesis by human decidua and placenta. Nature 1979, 281:317-319.
224. 3-1α-hydroxylase expression in normal and pathological, parathyroid glands. J Clin Endocrinol Metab 2002, 87:2967-2972.
225. 3 by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol 2002, 13:621-629.
226. 3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 1989, 93:1903-1915.
227. 3-induced growth inhibition. Cancer Res 2001, 61:2852-2856.
228. 3 24-hydroxylase expression in parathyroid tumors-new prospects for treatment of hyperparathyroidism with vitamin D. J Clin Endocrinol Metab 2002, 87:5826-5829.
229. Holick MF, Adams JS Vitamin D metabolism and biological function. Metabolic Bone Disease and Clinically Related Disorders 1990, 155-195. W. B. Saunders, Philadelphia, PA. L.V. Avioli, S.M. Krane (Eds.).
230. Adams JS Hypercalcemia due to granuloma-forming disorders. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 1996, 206-209. Lippincott-Raven, Philadelphia, PA. M.J. Favus, S. Christakos (Eds.).
231. Bouillon R, Okamura WH, Norman AW Structure-function relationships in the vitamin, D endocrine system. Endocr Rev 1995, 16:200-256.
232. Feldman D Imidazole derivatives as inhibitors of steroidogensis. Endocr Rev 1986, 7:409-430.
233. Glass AR, Eil C Ketoconazole-induced reduction in serum 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab 1986, 63:766-769.
234. 3 and total serum calcium in hypercalcemic patients. J Clin Endocrinol Metab 1988, 66:934-938.
235. Saggese G, Bertelloni S, Baroncelli GI, DiNero G Ketoconazole decreases the serum ionized calcium and 1,25-dihydroxyvitamin D levels in tuberculosis-associated hypercalcemia. AJDC 1993, 147:270-273.
236. Pont A, Williams PL, Loose DS, Feldman D, Reitz RE, Bochra C, Stevens DA Ketoconazole blocks adrenal steroid synthesis. Ann Int Med 1982, 97:370-372.
237. Adams JS, Lee G Recovery of bone mineral density following exogenous vitamin D intoxication. Ann Int Med 1997, 127.
238. Zehnder D, Bland R, Walker EA, Bradwell AR, Howie AJ, Hewison M, Stewart PM Expression of 25-hydroxyvitamin D 3-1α-hydroxylase in the human kidney. J Am Soc Nephrol 10:2465-2473.
239. Epstein S, Stern PH, Bell NH, Dowdeswell I, Turner RT Evidence for abnormal regulation of circulating 1α,25-dihydroxyvitamin D in patients with pulmonary tuberculosis and normal calcium metabolism. Calcif Tissue Int 36:541-544.
240. Isaacs RD, Nicholson GI, Holdaway IM. Miliary tuberculosis with hypercalcemia and raised vitamin D concentrations. Thorax 42:555-556.